Dianthus Therapeutics (DNTH) Stock Chart & Stock Price History $20.45 +0.95 (+4.87%) Closing price 04/21/2025 04:00 PM EasternExtended Trading$20.49 +0.04 (+0.20%) As of 04:52 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Dianthus Therapeutics Stock Price Performance 5 Day Performance+4.87%1 Month Performance+4.93%3 Month Performance-9.75%6 Month Performance-26.76%Year-To-Date Performance-6.19%1 Year Performance-12.01% Receive DNTH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dianthus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address DNTH Stock Chart for Tuesday, April, 22, 2025 DNTH Chart by TradingView Dianthus Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/21/2025$19.50$20.45+4.87%$21.40$18.65429,594 shs$656.98 million04/18/2025$19.50$19.50$19.70$18.87180,937 shs$626.46 million04/17/2025$18.98$19.50+2.74%$19.70$18.87180,937 shs$626.44 million04/16/2025$19.21$18.98-1.20%$19.53$18.37228,998 shs$609.73 million04/15/2025$18.71$19.21+2.67%$19.76$18.48314,429 shs$617.12 million04/14/2025$17.61$18.71+6.25%$19.11$17.16241,079 shs$601.06 million04/11/2025$15.60$17.61+12.88%$17.64$15.25304,304 shs$565.72 million04/10/2025$16.33$15.60-4.47%$17.00$14.51876,597 shs$501.15 million04/09/2025$14.86$16.33+9.89%$16.37$13.37961,742 shs$524.60 million04/09/2025$14.86$16.33+9.89%$16.37$13.37961,742 shs$524.60 million Get the Latest News and Ratings for DNTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dianthus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025$15.61$14.86-4.80%$16.66$14.60902,525 shs$477.38 million04/08/2025$15.61$14.86-4.80%$16.66$14.60902,525 shs$477.38 million04/07/2025$16.12$15.61-3.16%$16.69$14.93352,415 shs$501.47 million04/04/2025$16.97$16.12-5.01%$18.13$14.78398,315 shs$517.86 million04/03/2025$17.86$16.97-4.98%$17.42$15.89483,270 shs$545.16 million04/02/2025$16.83$17.86+6.12%$18.64$16.53949,121 shs$573.75 million04/01/2025$18.14$16.83-7.22%$17.98$16.44285,845 shs$540.66 million03/31/2025$19.99$18.14-9.25%$19.58$18.00332,710 shs$582.75 million03/28/2025$19.87$19.99+0.60%$20.45$19.22187,462 shs$642.18 million03/27/2025$18.27$19.87+8.76%$20.33$18.42200,918 shs$638.32 million03/26/2025$18.29$18.27-0.11%$18.82$17.50418,429 shs$586.92 million03/25/2025$19.41$18.29-5.77%$19.61$18.27303,216 shs$587.57 million03/24/2025$19.49$19.41-0.41%$21.77$19.38208,571 shs$623.55 million03/21/2025$20.44$19.49-4.65%$20.59$19.41239,200 shs$576.85 million Related Companies MoonLake Immunotherapeutics Stock Price Chart Alvotech Stock Price Chart Immunovant Stock Price Chart HUTCHMED Stock Price Chart ACADIA Pharmaceuticals Stock Price Chart Apellis Pharmaceuticals Stock Price Chart Amneal Pharmaceuticals Stock Price Chart Recursion Pharmaceuticals Stock Price Chart ImmunityBio Stock Price Chart Biohaven Stock Price Chart Receive DNTH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dianthus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DNTH) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredBiggest AI gains still ahead…? (Major announcement coming)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredTrade War Just Turned 3 Unknown Stocks Into Rocket FuelThe Real Catalyst Behind America’s Next Bull Run One overlooked sector is being completely repriced — and s...Insiders Exposed | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dianthus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dianthus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.